acetylcysteine has been researched along with Edema, Pulmonary in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, M; Lv, S; Qian, Y; Yu, H; Zhang, S; Zou, K | 1 |
| Auton, P; Fairhall, S; Graham, S; Jugg, B; Perrott, R; Rendell, R; Rutter, S; Smith, A | 1 |
| Antosova, M; Calkovska, A; Drgova, A; Mokra, D; Mokry, J; Petras, M | 1 |
| Antosova, M; Calkovska, A; Drgova, A; Durdik, P; Mokra, D; Mokry, J | 1 |
| Grinnell, K; Harrington, EO; Lu, Q; Newton, J; Ortiz, M; Rounds, S; Sakhatskyy, P; Sanchez-Esteban, J; Wang, Y | 1 |
| Andrade, L; Campos, R; Canale, D; de Bragança, AC; Lopes, FD; Olivo, C; Seguro, AC; Shimizu, MH; Volpini, RA | 1 |
| Grahn, H; Kuck, KH; Spangenberg, T; van der Schalk, H | 1 |
| Calkovska, A; Drgova, A; Kopincova, J; Mokra, D; Pullmann, R | 1 |
| Eisenhut, M | 1 |
| Diemel, RV; Hammer, AH; Joosen, MJ; Oostdijk, JP; van de Meent, D; van Esch, JH; van Helden, HP | 1 |
| Genest, M; Pochmalicki, G | 1 |
| Chen, HI; Chuang, IC; Kao, SJ; Liu, DD | 1 |
| Hallberg, A; Särnstrand, B; Sjödin, K; Tunek, A | 1 |
| Gurtner, GH; Kennedy, TP; Sciuto, AM; Strickland, PT | 1 |
| Delgado, R; Demitri, MT; Echtenacher, B; Faggioni, R; Gatti, S; Ghezzi, P; Gnocchi, P; Heremans, H | 1 |
| Echtenacher, B; Faggioni, R; Gatti, S; Ghezzi, P | 1 |
| Lailey, AF | 1 |
| Davreux, CJ; McGilvray, ID; Nathens, AB; Rotstein, OD; Shek, PN; Soric, I; Suntres, ZE; Watson, RW | 1 |
| Beltrame, JF; Brennan, RJ; Horowitz, JD; Hunt, A; Moran, JL; Unger, SA; Zeitz, CJ | 1 |
| Choi, IW; Choi, JH; Chung, WJ; Han, SJ; Han, SS; IM, SY; Jang, KY; Lee, DG; Lee, HB; Lee, HK; Park, KH | 1 |
| Hill, L; Lailey, AF; Lawston, IW; Stanton, D; Upshall, DG | 1 |
| Chan, KW; Saldeen, T; Sandhagen, B; Wegener, T | 1 |
2 review(s) available for acetylcysteine and Edema, Pulmonary
| Article | Year |
|---|---|
[Paraquat poisoning. Case report and overview].
Topics: Acetylcysteine; Acute Kidney Injury; Acute Lung Injury; Adult; Antioxidants; Ascorbic Acid; Combined Modality Therapy; Conscious Sedation; Cooperative Behavior; Critical Care; Dose-Response Relationship, Drug; Emergency Medical Services; Esophagoscopy; Esophagus; Gastric Mucosa; Hemofiltration; Herbicides; Humans; Interdisciplinary Communication; Intermittent Positive-Pressure Ventilation; Intestinal Mucosa; Male; Metabolic Clearance Rate; Oxygen Inhalation Therapy; Paraquat; Prognosis; Pulmonary Edema; Suicide, Attempted | 2012 |
[Diagnostic and therapeutic progress. Venous thromboembolism, cardiac insufficiency and radio contrast agents].
Topics: Acetylcysteine; Acute Disease; Adrenergic beta-Antagonists; Anticoagulants; Counterpulsation; Diastole; Diuretics; Echocardiography; Electric Countershock; Fibrin Fibrinogen Degradation Products; Fluid Therapy; Heart Failure; Hemofiltration; Heparin; Humans; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Oxygen Inhalation Therapy; Pulmonary Edema; Thromboembolism; Tissue Plasminogen Activator; Treatment Outcome; Vasodilator Agents; Venous Thrombosis | 2004 |
1 trial(s) available for acetylcysteine and Edema, Pulmonary
| Article | Year |
|---|---|
Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema.
Topics: Acetylcysteine; Acute Disease; Diuretics; Drug Tolerance; Female; Free Radical Scavengers; Furosemide; Humans; Male; Morphine; Nitroglycerin; Prospective Studies; Pulmonary Edema; Treatment Outcome | 1998 |
19 other study(ies) available for acetylcysteine and Edema, Pulmonary
| Article | Year |
|---|---|
Combination therapy with budesonide and acetylcysteine alleviates LPS-induced acute lung injury via the miR-381/NLRP3 molecular axis.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Budesonide; Lipopolysaccharides; Lung; MicroRNAs; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Edema; Rats; Signal Transduction | 2023 |
Assessment of N-acetylcysteine as a therapy for phosgene-induced acute lung injury.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Female; Glutathione; Lung; Phosgene; Pulmonary Edema; Respiratory Rate; Swine | 2018 |
N-acetylcysteine alleviates the meconium-induced acute lung injury.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Infant, Newborn; Injections, Intravenous; Intubation, Intratracheal; Leukocyte Count; Lipid Peroxidation; Lung; Meconium; Meconium Aspiration Syndrome; Oxidative Stress; Pulmonary Edema; Rabbits; Respiration, Artificial; Thiobarbituric Acid Reactive Substances; Trachea | 2015 |
N-acetylcysteine effectively diminished meconium-induced oxidative stress in adult rabbits.
Topics: Acetylcysteine; Age Factors; Animals; Antioxidants; Biomarkers; Disease Models, Animal; Humans; Infant, Newborn; Inflammation Mediators; Leukocytes; Lipid Peroxidation; Lung; Lung Injury; Meconium; Meconium Aspiration Syndrome; Mitochondria; Oxidative Stress; Pneumonia; Pulmonary Edema; Rabbits; Thiobarbituric Acid Reactive Substances; Time Factors | 2015 |
Cigarette smoke causes lung vascular barrier dysfunction via oxidative stress-mediated inhibition of RhoA and focal adhesion kinase.
Topics: Acetylcysteine; Actins; Adherens Junctions; Animals; Antioxidants; Cattle; Cell Line; Electric Impedance; Enzyme Activation; Epithelial Cells; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Nicotiana; Oxidative Stress; Permeability; Primary Cell Culture; Pulmonary Edema; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Smoke; Smoking | 2011 |
N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Cecum; Disease Models, Animal; Glomerular Filtration Rate; Kidney; Lung; Male; Neutrophils; Oxidative Stress; Pulmonary Edema; Rats; Rats, Wistar; Respiration, Artificial; Sepsis; Sodium Channels; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2 | 2012 |
Anti-inflammatory treatment in dysfunction of pulmonary surfactant in meconium-induced acute lung injury.
Topics: Acetylcysteine; Acute Lung Injury; Aminophylline; Animals; Anti-Inflammatory Agents; Antioxidants; Bronchoalveolar Lavage Fluid; Budesonide; Dexamethasone; Disease Models, Animal; Humans; Imidazoles; Infant, Newborn; Leukocyte Count; Lung; Meconium; Meconium Aspiration Syndrome; Neutrophils; Oxidative Stress; Phosphodiesterase Inhibitors; Pulmonary Edema; Pulmonary Surfactants; Pyridones; Rabbits | 2013 |
Role of nitric oxide metabolites in reduction of sodium potassium ATPase dependent pulmonary edema clearance.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Male; Pulmonary Edema; Respiration, Artificial; Sepsis | 2012 |
Protection of rats against perfluoroisobutene (PFIB)-induced pulmonary edema by curosurf and N-acetylcysteine.
Topics: Acetylcysteine; Administration, Inhalation; Animals; Animals, Outbred Strains; Biological Products; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Expectorants; Fluorocarbons; Inhalation Exposure; Lung; Male; Organ Size; Phospholipids; Proteins; Pulmonary Edema; Rats; Rats, Wistar; Respiratory Function Tests; Specific Pathogen-Free Organisms; Surface Tension | 2004 |
N-acetylcysteine attenuates the acute lung injury caused by phorbol myristate acetate in isolated rat lungs.
Topics: Acetylcysteine; Acute Disease; Animals; Blood Pressure; Body Weight; Bronchoalveolar Lavage Fluid; Capillary Permeability; Expectorants; Free Radical Scavengers; In Vitro Techniques; Inflammation Mediators; Lung; Lung Diseases; Male; Nitric Oxide; Organ Size; Pulmonary Artery; Pulmonary Edema; Random Allocation; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate | 2007 |
Effects of N-acetylcysteine stereoisomers on oxygen-induced lung injury in rats.
Topics: Acetylcysteine; Administration, Oral; Animals; Cysteine; Disease Models, Animal; Glutathione; Hyperemia; Infusion Pumps, Implantable; Infusions, Intravenous; Lung; Male; Osmosis; Oxygen; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Stereoisomerism | 1995 |
Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits.
Topics: Acetylcysteine; Animals; Antioxidants; Glutathione; Leukotrienes; Lipid Peroxidation; Lung; Male; Oxidation-Reduction; Phosgene; Pulmonary Edema; Rabbits; Time Factors | 1995 |
Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema.
Topics: Acetylcysteine; Allopurinol; Animals; Interferon-gamma; Interleukin-1; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Pulmonary Edema; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Xanthine Oxidase | 1994 |
Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality.
Topics: Acetylcysteine; Animals; Antibodies, Monoclonal; Bronchoalveolar Lavage Fluid; Chlorpromazine; Dexamethasone; Disease Models, Animal; Endotoxins; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Neutrophils; Pulmonary Edema; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 1993 |
Oral N-acetylcysteine protects against perfluoroisobutene toxicity in rats.
Topics: Acetylcysteine; Administration, Oral; Animals; Bronchoalveolar Lavage Fluid; Cysteine; Female; Fluorocarbons; Glutathione; Lung; Pulmonary Edema; Rats; Rats, Wistar | 1997 |
N-acetyl cysteine attenuates acute lung injury in the rat.
Topics: Acetylcysteine; Acute Disease; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Capillary Permeability; CD11 Antigens; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxins; Glutathione; Hemorrhage; Lipid Peroxidation; Lipopolysaccharides; Liver; Lung; Lung Diseases; Lung Injury; Male; Neutrophil Activation; Neutrophils; Peroxidase; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1997 |
Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB.
Topics: Acetylcysteine; Animals; Antioxidants; Azepines; Benzoquinones; Disseminated Intravascular Coagulation; DNA-Binding Proteins; Female; Gene Expression Regulation; Genistein; Hemorrhage; Hydrogen Peroxide; I-kappa B Proteins; Isoflavones; Kidney Medulla; Lactams, Macrocyclic; Lethal Dose 50; Macrophages; Mice; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Platelet Activating Factor; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pulmonary Edema; Pyrrolidines; Quinones; Reactive Oxygen Species; Rifabutin; Serine Proteinase Inhibitors; Signal Transduction; Specific Pathogen-Free Organisms; Succinic Acid; Thiocarbamates; Tosylphenylalanyl Chloromethyl Ketone; Triazoles; Tumor Necrosis Factor-alpha; Vitamin E | 2000 |
Protection by cysteine esters against chemically induced pulmonary oedema.
Topics: Acetylcysteine; Animals; Buthionine Sulfoximine; Chromatography, High Pressure Liquid; Cysteine; Cystine; DNA; Female; Fluorocarbons; Glutathione; Liver; Lung; Methionine Sulfoximine; Perfusion; Pulmonary Edema; Rats; Sulfhydryl Compounds; Time Factors | 1991 |
N-acetylcysteine in paraquat toxicity: toxicological and histological evaluation in rats.
Topics: Acetylcysteine; Animals; Body Weight; Lung; Male; Organ Size; Paraquat; Pulmonary Edema; Rats; Rats, Inbred Strains | 1988 |